What is the recommended dosage of amoxicillin (amoxicillin) + potassium clavulanate for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing for Pediatric Patients

For most pediatric infections requiring amoxicillin-clavulanate, the recommended dosage is 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate, divided into 2 doses daily, with a maximum of 4000 mg amoxicillin per day. 1

Standard High-Dose Regimen

The high-dose formulation provides a 14:1 ratio of amoxicillin to clavulanate and is the preferred regimen for most pediatric infections, particularly respiratory tract infections. 1 This dosing achieves adequate tissue concentrations to overcome penicillin-resistant Streptococcus pneumoniae and β-lactamase-producing organisms. 1

Key dosing parameters:

  • 90 mg/kg/day of amoxicillin component divided into 2 doses 1
  • 6.4 mg/kg/day of clavulanate 1
  • Maximum single dose: 2000 mg of amoxicillin 1
  • Maximum daily dose: 4000 mg of amoxicillin 1

Age-Specific Dosing

Neonates and Infants < 3 Months

  • 30 mg/kg/day divided every 12 hours based on the amoxicillin component 2
  • Use the 125 mg/31.25 mg per 5 mL oral suspension formulation 2

Infants and Children ≥ 3 Months

  • Standard dose: 45 mg/kg/day in 3 doses OR 90 mg/kg/day in 2 doses 1
  • The twice-daily regimen (90 mg/kg/day) is preferred as it significantly reduces diarrhea compared to three-times-daily dosing 2

Children Weighing ≥ 40 kg

  • Dose according to adult recommendations 2
  • For severe respiratory infections: 875 mg/125 mg every 12 hours 2

Indication-Specific Dosing

Respiratory Tract Infections (Pneumonia, Sinusitis)

  • High-dose regimen: 90 mg/kg/day in 2 divided doses for children at risk of resistant organisms 3, 1
  • Risk factors include: age < 2 years, daycare attendance, recent antibiotic use (within 4-6 weeks), moderate-to-severe illness 1
  • Duration: 10 days for most respiratory infections 1

β-Lactamase Producing H. influenzae

  • 45 mg/kg/day in 3 doses OR 90 mg/kg/day in 2 doses 1
  • The twice-daily regimen is preferred for better adherence and fewer gastrointestinal side effects 2

Preseptal Cellulitis

  • 80-90 mg/kg/day of amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses 4
  • Duration: 10-14 days, with some experts recommending continuation until 7 days symptom-free 4
  • Evaluate for clinical improvement within 48-72 hours 4

Alternative Lower-Dose Regimen

For mild infections in children without risk factors for resistant organisms:

  • 45 mg/kg/day in 2 doses may be considered 5
  • However, this is generally not recommended as first-line for most infections requiring amoxicillin-clavulanate 1

Practical Dosing by Suspension Concentration

Using 125 mg/31.25 mg per 5 mL suspension:

  • Ages 1-12 months: 2.5 mL three times daily (standard dose) 1
  • Ages 1-6 years: 5 mL three times daily (standard dose) 1

Using 250 mg/62.5 mg per 5 mL suspension:

  • Ages 7-12 years: 5 mL three times daily (standard dose) 1

Critical caveat: These are standard-dose regimens. For high-dose therapy (90 mg/kg/day), calculate the exact volume based on the child's weight and the suspension concentration being used. 1

Intravenous Dosing

For severe infections requiring IV therapy:

  • 30 mg/kg three times daily IV for all pediatric ages 1
  • Consider IV therapy for children unable to tolerate oral medication or with severe infections 4

Common Pitfalls to Avoid

Do not underdose: Using standard doses when high-dose therapy is indicated leads to treatment failure with resistant organisms. 1 The difference between 45 mg/kg/day and 90 mg/kg/day is clinically significant for resistant pathogens. 1

Verify suspension concentration: Always confirm whether you're using 125/31 or 250/62 suspension before calculating volume to avoid dosing errors. 1

Do not substitute formulations: Two 250 mg/125 mg tablets are NOT equivalent to one 500 mg/125 mg tablet due to different clavulanate content. 2 Similarly, different chewable tablet formulations are not interchangeable. 2

Phenylketonuria warning: The 200 mg/28.5 mg per 5 mL and 400 mg/57 mg per 5 mL suspensions contain aspartame and should not be used in phenylketonuric patients. 2

Monitoring and Follow-Up

  • Expect clinical improvement within 48-72 hours of starting therapy 1, 4
  • If no improvement or worsening occurs after 72 hours, reevaluate and consider switching antibiotics or further investigation 3, 1
  • Complete the full course even if symptoms improve before completion 1

Adverse Effects

The most common adverse effects are gastrointestinal, including diarrhea, nausea, and vomiting. 1 The high-dose 14:1 ratio formulation (90/6.4 mg/kg/day) causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining efficacy. 1 Recent evidence suggests even lower clavulanate concentrations (80 mg amoxicillin/2.85 mg clavulanate/kg/day) may reduce side effects without compromising efficacy, though this is not yet standard practice. 6

Storage and Preparation

Reconstituted oral suspension must be stored under refrigeration and discarded after 10 days. 2 Shake well before each use. 2

References

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin-Clavulanate Dosage for Pediatric Preseptal Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.